MEDICAL SERVICES

Specialties

Departments

Programs

Languages

  • English

  • Spanish

EDUCATION

Undergraduate Degree

  • Haverford College , 2000 , Haverford , PA

Medical School

  • Harvard Medical School , 2005 , Boston , MA

Residency

Pediatrics
  • Boston Combined Residency Program (BCRP) , 2008 , Boston , MA

Residency

Chief Resident
  • Boston Combined Residency Program (BCRP) , 2009 , Boston , MA

Fellowship

Pediatric Endocrinology
  • Boston Children's Hospital , 2012 , Boston , MA

PROFESSIONAL HISTORY

Dr. Ari Wassner is Medical Director of the Thyroid Center at Boston Children’s Hospital and Assistant Professor of Pediatrics at Harvard Medical School in Boston, Massachusetts. He earned his MD from Harvard Medical School, and he completed his residency and chief residency in Pediatrics followed by his fellowship in Pediatric Endocrinology at Boston Children’s Hospital. In addition to practicing general pediatric endocrinology, Dr. Wassner’s clinical specialties are in pediatric thyroid disease and pediatric endocrine tumors, and he is actively engaged in clinical research in these areas.

CERTIFICATIONS

  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Pediatric Endocrinology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Predictors of Bilateral Disease in Pediatric Differentiated Thyroid Cancer. J Clin Endocrinol Metab. 2021 Sep 27; 106(10):e4242-e4250. View abstract
  2. Clinical utility of sonographic features in indeterminate pediatric thyroid nodules. Eur J Endocrinol. 2021 May; 184(5):657-665. View abstract
  3. Re: "The Use of the Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: A Meta-Analysis" by Vuong et al. Thyroid. 2021 09; 31(9):1441. View abstract
  4. Relationship of Preoperative Thyroid Dysfunction to Clinical Outcomes in Pediatric Cardiac Surgery. J Clin Endocrinol Metab. 2021 04 23; 106(5):e2129-e2136. View abstract
  5. Risk Stratification in Pediatric Thyroid Cancer: Growing Evidence for Individualized Therapy. J Clin Endocrinol Metab. 2021 03 08; 106(3):e1471-e1472. View abstract
  6. Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome. J Clin Endocrinol Metab. 2021 03 08; 106(3):e1121-e1130. View abstract
  7. Severity of Proteinuria Is Directly Associated With Risk of Hypothyroidism in Adults. J Clin Endocrinol Metab. 2021 01 23; 106(2):e757-e762. View abstract
  8. Consensus statement by the American Association of Clinical Endocrinology (AACE) and the American Head and Neck Society Endocrine Surgery Section (AHNS-ES) on Pediatric Benign and Malignant Thyroid Surgery. Head Neck. 2021 04; 43(4):1027-1042. View abstract
  9. Graves' disease in a five-month-old boy with an unusual treatment course. J Pediatr Endocrinol Metab. 2021 Mar 26; 34(3):401-406. View abstract
  10. Consensus Statement by the American Association of Clinical Endocrinology (AACE) and the American Head and Neck Society Endocrine Surgery Section (AHNS) on Pediatric Benign and Malignant Thyroid Surgery. Endocr Pract. 2021 Mar; 27(3):174-184. View abstract
  11. Undernutrition and Pubertal Timing in Female Survivors of Medulloblastoma and Other Embryonal Tumors. J Clin Endocrinol Metab. 2020 10 01; 105(10). View abstract
  12. Unraveling the Genetics of Congenital Hypothyroidism: Challenges and Opportunities. J Clin Endocrinol Metab. 2020 09 01; 105(9). View abstract
  13. MCT8 deficiency: collaborative rare disease phenotyping for care and research. Lancet Diabetes Endocrinol. 2020 07; 8(7):555-557. View abstract
  14. Update on congenital hypothyroidism. Curr Opin Endocrinol Diabetes Obes. 2020 02; 27(1):63-69. View abstract
  15. Assessment of American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) for Pediatric Thyroid Nodules. Radiology. 2020 02; 294(2):415-420. View abstract
  16. A Novel ALK Fusion in Pediatric Medullary Thyroid Carcinoma. Thyroid. 2019 11; 29(11):1704-1707. View abstract
  17. COINCIDENT SUPPURATIVE THYROIDITIS AND GRAVES DISEASE IN A PATIENT WITH INFECTED BRANCHIAL CLEFT CYST. AACE Clin Case Rep. 2019 Nov-Dec; 5(6):e365-e368. View abstract
  18. Differences in Thyroid Nodule Cytology and Malignancy Risk Between Children and Adults. Thyroid. 2019 08; 29(8):1097-1104. View abstract
  19. Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism. Endocrine. 2019 10; 66(1):51-62. View abstract
  20. Natural History and Outcomes of Cytologically Benign Thyroid Nodules in Children. J Clin Endocrinol Metab. 2018 09 01; 103(9):3557-3565. View abstract
  21. Thyroid Nodules in Pediatric Patients: Sonographic Characteristics and Likelihood of Cancer. Radiology. 2018 08; 288(2):591-599. View abstract
  22. Congenital Hypothyroidism. Clin Perinatol. 2018 03; 45(1):1-18. View abstract
  23. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int. 2018 01; 93(1):204-213. View abstract
  24. Congenital hypothyroidism: insights into pathogenesis and treatment. Int J Pediatr Endocrinol. 2017; 2017:11. View abstract
  25. Prevalence and Significance of Thyroglobulin Antibodies in Pediatric Thyroid Cancer. J Clin Endocrinol Metab. 2017 09 01; 102(9):3146-3153. View abstract
  26. Pediatric Hypothyroidism: Diagnosis and Treatment. Paediatr Drugs. 2017 Aug; 19(4):291-301. View abstract
  27. Myocardial Induction of Type 3 Deiodinase in Dilated Cardiomyopathy. Thyroid. 2017 05; 27(5):732-737. View abstract
  28. Mutations in SLC26A1 Cause Nephrolithiasis. Am J Hum Genet. 2016 06 02; 98(6):1228-1234. View abstract
  29. Liothyronine Improves Biochemical Control of Congenital Hypothyroidism in Patients with Central Resistance to Thyroid Hormone. J Pediatr. 2016 08; 175:167-172.e1. View abstract
  30. Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis. Clin J Am Soc Nephrol. 2016 Apr 07; 11(4):664-72. View abstract
  31. Subclinical Hypothyroidism in Infancy: To Treat or Not to Treat, That Is the Question. J Pediatr. 2016 Mar; 170:17-9. View abstract
  32. Congenital hypothyroidism: recent advances. Curr Opin Endocrinol Diabetes Obes. 2015 Oct; 22(5):407-12. View abstract
  33. Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol. 2015 Mar; 26(3):543-51. View abstract
  34. Mice with hepatocyte-specific deficiency of type 3 deiodinase have intact liver regeneration and accelerated recovery from nonthyroidal illness after toxin-induced hepatonecrosis. Endocrinology. 2014 Oct; 155(10):4061-8. View abstract
  35. Severe hypercalcaemia due to subcutaneous fat necrosis: presentation, management and complications. Arch Dis Child Fetal Neonatal Ed. 2014 Sep; 99(5):F419-21. View abstract
  36. How are childhood thyroid nodules discovered: opportunities for improving early detection. J Pediatr. 2014 Mar; 164(3):658-60. View abstract
  37. Rates of medical errors and preventable adverse events among hospitalized children following implementation of a resident handoff bundle. JAMA. 2013 Dec 04; 310(21):2262-70. View abstract
  38. Endocrine physiology in the newborn. Semin Pediatr Surg. 2013 Nov; 22(4):205-10. View abstract
  39. Hypothyroidism in the newborn period. Curr Opin Endocrinol Diabetes Obes. 2013 Oct; 20(5):449-54. View abstract
  40. A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults. J Clin Endocrinol Metab. 2013 Aug; 98(8):3238-45. View abstract
  41. Isolated central hypothyroidism in young siblings as a manifestation of PROP1 deficiency: clinical impact of whole exome sequencing. Horm Res Paediatr. 2013; 79(6):379-86. View abstract
  42. Synthesis and ion conductance behavior of a tetrameric alamethicin ion channel. Org Lett. 2002 May 16; 4(10):1647-9. View abstract